Search Results - "ALAGARSAMY, Sudar"

The Contribution of Protease-Activated Receptor 1 to Neuronal Damage Caused by Transient Focal Cerebral Ischemia by Junge, Candice E., Sugawara, Taku, Mannaioni, Guido, Alagarsamy, Sudar, Conn, P. Jeffrey, Brat, Daniel J., Chan, Pak H., Traynelis, Stephen F.

“…The serine proteases tissue plasminogen activator, plasmin, and thrombin and their receptors have previously been suggested to contribute to neuronal damage in…”
Get full text

NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin by Alagarsamy, Sudar, Saugstad, Julie, Warren, Lee, Mansuy, Isabelle M., Gereau, Robert W., Conn, P. Jeffrey

“…Previous reports have shown that activation of N-methyl- d-aspartate (NMDA) receptors potentiates responses to activation of the group I metabotropic glutamate…”
Get full text

Metabotropic glutamate receptors modulate feedback inhibition in a developmentally regulated manner in rat dentate gyrus by Doherty, James J., Alagarsamy, Sudar, Bough, Kristopher J., Conn, P. Jeffrey, Dingledine, Raymond, Mott, David D.

“…We investigated group II metabotropic glutamate receptor (mGluR) modulation of glutamatergic input onto hilar-border interneurones and its regulation of…”
Get full text

Abstract 17120: ARO-ANG3, an Investigational RNAi Therapeutic, Silences the Expression of ANGPTL3 and Decreases Atherogenic Lipoproteins in Patients With Mixed Dyslipidemia: ARCHES-2 Study Results by Watts, Gerald F, Gaudet, Daniel, ALTAMIRANO, DARIO, Hegele, Robert, Ballantyne, Christie M, Nicholls, Stephen, Chang, Ting, Alagarsamy, Sudar, Fu, Ran, San Martin, Javier, Rosenson, Robert S

“…Abstract only Background: Angiopoietin-like protein 3 (ANGPTL3) regulates lipoprotein metabolism by inhibiting lipoprotein and endothelial lipases. ANGPTL3…”
Get full text

Pharmacological Characterization of FE 203799, a Novel Long Acting Peptide Analog of Glucagon-Like Peptide-2 (GLP-2) by Hargrove, Diane M, Alagarsamy, Sudar, Qi, Steve, Srinivasan, Karthik, Croston, Glenn, Laporte, Regent, Sueiras-Diaz, Javier, Wisniewski, Kazimierz, Hartwig, Jennifer, Wisniewska, Halina T, Lu, Mark, Posch, Alexander P, Schteingart, Claudio D, Rivière, Pierre J

Get full text

Synthesis and in vitro pharmacological profile of potent and selective peptidic V1a receptor agonists by Wisniewski, Kazimierz, Galyean, Robert, Taki, Hiroe, Alagarsamy, Sudar, Croston, Glenn, Laporte, Regent, Schteingart, Claudio D, Rivière, Pierre J M

Get more information

NMDA-induced phosphorylation and regulation of mGluR5 by Alagarsamy, Sudar, Rouse, Susan T, Junge, Candace, Hubert, G.W, Gutman, David, Smith, Yoland, Conn, P.Jeffrey

“…Glutamate regulates neuronal function by acting on ionotropic receptors such as the N-methyl- d-aspartate (NMDA) receptor and metabotropic receptors (mGluRs)…”
Get full text

Localization of the P3 sources using magnetoencephalography and magnetic resonance imaging by Rogers, R L, Baumann, S B, Papanicolaou, A C, Bourbon, T W, Alagarsamy, S, Eisenberg, H M

“…In this study, two related issues were addressed: first, whether the P3 component of auditory evoked responses, obtained in the context of an oddball paradigm,…”
Get more information

NMDA-induced phosphorylation and regulation of mGluR5: Metabotropic glutamate receptors by ALAGARSAMY, Sudar, ROUSE, Susan T, JUNGE, Candace, HUBERT, G. W, GUTMAN, David, SMITH, Yoland, CONN, P. Jeffrey

Get full text

HIV decreases glutamate transport in SK-N-MC neuroblastoma cells by Pappas, T C, Alagarsamy, S, Pollard, R B, Nokta, M

“…Autopsy studies of patients with AIDS dementia have shown neuronal loss consistent with a neurotoxic component of this disease. In vitro studies suggest that…”
Get more information